Michael M. Buchman is a partner in the New York, New York office of Saveri Law Firm LLP. His practice focuses on complex antitrust litigation and Mass Tort Litigation / Class Actions - Plaintiffs. He represents plaintiffs in matters involving competition law, market conduct, and consumer protection, and has handled antitrust disputes in courts across the United States as well as in matters involving international competition issues.
Before joining Saveri Law Firm LLP, Michael earned an LL.M. in International Antitrust & Trade Law from Fordham University School of Law. Earlier in his career, he worked with a London barrister on matters involving European Union competition law. He also served as an Assistant Attorney General in the Antitrust Bureau of the New York State Attorney General’s Office. In private practice, he held leadership roles within the antitrust practice groups of two class action law firms.
Michael has represented a wide range of clients in complex antitrust and class action litigation, including a foreign government, U.S. states, municipalities, union health and welfare plans, retailers, and consumers. His work includes participation in major antitrust class actions brought under the Sherman Act, including In re NASDAQ Market-Makers Antitrust Litigation, which resulted in a $1.027 billion settlement, and In re Payment Card Interchange Fee and Merchant Discount Antitrust Litigation, which resulted in a $5.5 billion settlement. In the Payment Card case, he represented the largest class representative retailer plaintiff.
For nearly three decades, Michael has been involved in litigation addressing competition issues in the pharmaceutical industry, including cases related to generic drug market entry and reverse payment claims. He has served on trial teams in these matters, including In re Solodyn Antitrust Litigation, an end-payor reverse payment case that resolved during the third week of trial. In 2025, he helped secure a $198.4 million settlement in In re Xyrem (Sodium Oxybate) Antitrust Litigation, one of the largest end-payor settlements in a reverse payment antitrust case. He has also served twice as Co-Chair of HarrisMartin’s Antitrust Pay-For-Delay Litigation Conference.
Michael has written and co-authored publications addressing antitrust law, competition policy, and litigation procedure. His work includes participation in a Task Force on Dealer Terminations for The Association of the Bar of the City of New York, Committee on Antitrust and Trade Regulation, which contributed to the publication Dealer Termination in New York. He also co-authored What's in a Name—The Diversity Death-Knell for Underwriters of Lloyd's of London and their Names; Humm v. Lombard World Trade, Inc., published in the International Insurance Law Review.
In addition to his legal practice, Michael participates in community matters in the New York and Connecticut areas. He previously served on the Flood and Erosion Committee for the Town of Westport, Connecticut. He also serves as pro bono counsel in long-running litigation concerning the alleged misappropriation of perpetual care funds at Bayside Cemetery, a 12-acre cemetery with approximately 34,000 plots located in Queens, New York.